Global Health
- Short interest
- 0.02%
- +0.01 pp 30d
- as of 6 Aug 2025
- Reported shorts
- 8.9K
- Shares on issue
- 58.575M
Global Health (GLH) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26), figures in AUD, the reporting currency
- Revenue
- $7.2Mvs n/a
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- −$758.2Kvs n/a
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- −$0.013vs n/a
- Yahoo Finance, as at 14 Oct 2026
- Rev YoY
- n/aFY
- EPS YoY
- n/aTTM
Summary of 2026 Appendix 4E and Full Year Statutory Accounts, 27 Aug 2026
Global Health Limited reported a 1.84% decline in revenue to $7.18 million for FY2026, with net loss improving 12.51% to $758,220. No dividends were paid or declared. The company highlighted a 5.5% increase in Annual Recurring Revenue (ARR) to $6.674 million and a 28% improvement in EBITDA to ($545K), driven by cost reductions and AI adoption.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 14 Oct 2026
- Gross margin
- 100.0%
- Operating margin
- −19.6%
- Net margin
- −10.6%
- FCF margin
- −1.3%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- $853.9K
- Net debt / EBITDA
- n/a
- Current ratio
- 0.3×
- Interest cover
- −6.9×
- Cash dividends paid / net profit
- n/a
- Market cap
- $3.5M
- P/E
- n/a
- P/B
- n/a
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $7.2M | $8.1M | $7.8M | $6.5M |
| Gross profit | $7.2M | $8.1M | $7.8M | $6.5M |
| Operating income | −$1.4M | −$1.8M | −$3.7M | −$2.0M |
| EBITDA | −$545.6K | −$1.2M | −$7.1M | −$1.7M |
| EBIT | −$555.9K | −$1.2M | −$7.6M | −$2.0M |
| Interest expense | $202.3K | $95.2K | $69.5K | $33.3K |
| Pretax income | −$758.2K | −$1.3M | −$7.7M | −$2.0M |
| Tax | $0 | $0 | $354.9K | $39.6K |
| NPAT | −$758.2K | −$1.3M | −$8.1M | −$2.0M |
| Net interest income | −$187.9K | −$86.6K | −$73.4K | −$33.3K |
| EPS basic | −$0.013 | −$0.023 | −$0.14 | −$0.037 |
| EPS diluted | −$0.013 | −$0.023 | −$0.14 | −$0.037 |
| Shares | 58.8M | 58.0M | 58.0M | 56.6M |
Financial reports
The company's own filings, newest first
- 2026 Appendix 4E and Full Year Statutory AccountsAnnual Results27 Aug 2026via asx_announcements
- June 2026 Quarterly Business Activity report and Appendix 4CQuarterly Report23 Jul 2026via asx_announcements
- March-26 QTR Business Activity Report and Appendix 4CQuarterly Report22 Apr 2026via asx_announcements
- Dec 2025 Appendix 4D and Half Year AccountsHalf Year Results25 Feb 2026via asx_announcements
- GLH December 2025 Half Year Results SummaryHalf Year Results25 Feb 2026via asx_announcements
- GLH Appendix 4C December 25 QTR Cash Flow ReportQuarterly Report19 Jan 2026via asx_announcements
- Amendment Cover page for Appendix 4C December 25 QTRQuarterly Report19 Jan 2026via asx_announcements
- Option Exercise FormFinancial Report31 Dec 2025via crawler
- 2025 Appendix 4E and Full Year Statutory AccountsAnnual Results27 Aug 2025via asx_announcements
- June 25 Quarterly Activities Report and Appendix 4CQuarterly Report28 Jul 2025via asx_announcements
Showing 10 of 22 reports